Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish Familial Mediterranean Fever patients with and without amyloidosis

References

• Centola M, Aksentijevich I, Kastner D L. The hereditary periodic fever syndromes: molecular analysis of a new family of inflammatory diseases. Hum Mol Genet 1998; 7: 1581–1588
   PubMed Web of Science ®Google Scholar
• Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 1967; 43: 227–253
   PubMed Web of Science ®Google Scholar
• Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Eng J Med 1986; 1001–1005
   PubMed Web of Science ®Google Scholar
• Özer F L, Kaplan E, Zileli S. Familial Mediterranean Fever in Turkey. Am J Med 1971; 53: 336–339
   Google Scholar
• Özdemir A I, Sokmen C. Familial Mediterranean Fever among the Turkish people. Am J Gastroenterol 1969; 51: 311–316
   PubMed Web of Science ®Google Scholar
• Saatçi Ü, Özen S, Özdemir S, Bakkaglolu A, Besbas N, Topaloglu R, Arslan S. Familial Mediterranean Fever in children: report of a large series and discussion of prognostic factors of amyloidosis. Eur J Pedtatr 1997; 156: 619–623
   PubMed Web of Science ®Google Scholar
• Yalclinkaya F, Tümer N, Tekin M, Clakar N, AkcLakus M. Familial Mediterranean Fever in Turkish children (analysis of 110 cases). Familial Mediterranean Fever, E Sohar, J Gafni, M Pras. Freund Publishing House, Tel Aviv 1997; 157–161
   Google Scholar
• The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997; 90: 797–807
   PubMed Web of Science ®Google Scholar
• The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nature Genet 1997; 17: 25–31
   PubMed Web of Science ®Google Scholar
• Touitou I (2000) The spectrum of FMF Mutations in familial Mediterranean Fever, 11. International Conference. Lectures and Abstracts, AntalyaTurkey, May, 3–72000, 123–26
   Google Scholar
• Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner D L, Pras M, Pras E. MEFV mutations analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid: Int J Exp Clin Invest 1999; 6: 1–6
   PubMed Web of Science ®Google Scholar
• Shohat M, Magal N, Shohat T, Chen X, Dagan T, Mimouni A, Danon Y, Lotan R, Ogur G, Sirin A, Schlezinger M, Halpem G J, Schwabe A, Kastner D L, Rotter J I, Fischel‐Ghodsian N. Phenotype‐ genotype correlations in familial‐Mediterranean fever: evidence for an association between Met 694 Val and amyloidosis. Eur J Hum Genet 1999; 3: 287–292
   Google Scholar
• Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, Nedelec B, Reinert P, Ayvazyan A, Kouyoumdjian J C, Ajrapetyan H, Delpech M, Goossens M, Dode C, Grateau G, Amselem S. MEFV‐gene analysis in Armenian patients with familial Mediterranean fever. Diagnostic value and unfavorable renal prognosis of the M694V homozygous genotypegenetic and therapeutic implications. Am J Hum Genet 1999; 65: 88–97
   PubMed Web of Science ®Google Scholar
• Yalclinkaya F, Akar N, Misirliogu M. Familial Mediterranean fever‐ amyloidosis and the Val 726Ala mutations. N. Eng J Med 1998; 338: 993–994
   PubMed Web of Science ®Google Scholar
• Akar N, Misirlioglu M, Yalcinkaya F, Akar E, Cakar N, Tumer N, Akcakus M, Tastan H, Matzner Y. MEFV mutations in Turkish patients suffering from familial Mediterranean fever. Human Mutation 2000; 15: 118–119
   PubMed Web of Science ®Google Scholar
• Akar N, Yalqinkaya F, Akar E, Cakar N. MEFV mutation analysis in Turkish familial Mediterranean fever patients with amyloidosis. Amyloid: Int J Exp Clin Invest 1999; 6: 301–302
   PubMed Web of Science ®Google Scholar
• Yalclinkaya F, Cakar N, Misirliogu M, Tumer N, Akar N, Tekin M, Tastan H, Koclak H, Özkaya N, Elhan A H. Genotype‐phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation independent amyloidosis. Rheumatology 2000; 39: 67–72
   PubMed Web of Science ®Google Scholar
• Yamada T, Okuda Y, Itoh Y. The frequency of serum amyloid A2 alleles in the Japanese population. Amyloid: Int J Exp Clin Invest 1998; 5: 208–211
   PubMed Web of Science ®Google Scholar
• Moriguchi M, Terai C, Koseki Y, Uesato M, Nakajima A, lnada S, Nishinarita M, Uchida S, Nakajima A, Kim S Y, Chen C, Kamatani N. Influence of genotypes at SAAl and SAA2 loci on the development and the length of latent period of secondary AA amyloidosis in patients with rheumatoid arthritis. Hum Genet 1999; 105: 360–366
   PubMed Web of Science ®Google Scholar
• Revised nomenclature for serum amyloid A (SAA). Amyloid: Int J Exp Clin Invest 1999; 6: 67–70, Editorial
   PubMed Web of Science ®Google Scholar
• Baba S, Masago S A, Takahashi T, Kasama T, Sugimura H, Tsugane S, Tusutsui Y, Shirasawa H. A novel allelic variant of serum amyloid A, SAAIγ genomic evidence, evolution, frequency and implication as a risk factor for reactive systemic AA‐amyloidosis. Hum Mol Genet 1995; 4: 1083–1087
   PubMed Web of Science ®Google Scholar
• Moriguchi M, Terai C, Kaneko H, Koseki Y, Kajiyama H, Uesato M, Inada S, Kamatani N. A novel single‐nucleotide polymorphism at the 5'‐flanking region of SAAI associated with risk of type AA amyloidosis secondary to rheumatoid arthritis. Arthritis Rheum 2001; 44: 1266–1272
   PubMed Web of Science ®Google Scholar
• Cazeneuve C, Ajrapetyan H, Papin S, Thoroval F R, Genevieve D, Mndjoyan E, Papazian M, Sarkisian A, Babloyan A, Boissier B, Duguesnay P, Kouyoumdjian J, Giradan‐Boulandet E, Grateau G, Sarkisian T, Amselem S. Identification of MEFV‐ Independent modifying genetic factors for Familial Mediterranean fever. Am J Hum Genet 2000; 67: 1136–1143
   PubMed Web of Science ®Google Scholar
• Wilson A, Symons J, McDowelI T, Mc Dewitt H, Duff G. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptinal activation. Proc Natl Acad Sci 1997; 94: 3195–3199
   PubMed Web of Science ®Google Scholar
• Touitou I, Picot M C, Domingo C, Notarnicola C, Cattan D, Demaille J, Kone‐ Paul I. The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum 2001; 44: 163–169
   PubMed Web of Science ®Google Scholar
• Livneh A, Langevita P, Zemer D, Zaks N, Kees S, Lidar T, Pras M. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879–1885
   PubMed Web of Science ®Google Scholar
• Akar H, Keven K, Nergizoglu G, Erturk S, Ates K, Erbay B, Akar N, Duman N, Karatan O. Renal amyloidosis in a patient with homozygous sickle cell anemia and M694V/M694V mutation. Nephron 2000; 86: 383–4
   PubMed Web of Science ®Google Scholar
• Brown K, Luddington R, Baglin T. A common polymorphism in the tumor necrosis factor‐alpha gene associated with high TNF levels is not a risk factor for venous thrombo‐embolism. Br J Haematol 1998; 101: 480–482
   PubMed Web of Science ®Google Scholar
• Akar N, Hasipek M. Tumor Necrosis Factor‐alpha gene polymorphism (‐308 G‐A) in Turkish Pediatric Thrombosis Patients. Turk J Haemat 2002; 19: 39–41
   PubMedGoogle Scholar
• Tekin M, Yalqinkaya F, Clakar N, Akar N, Misirliogu M, Tastan H, Türner N. MEFV mutations in multiplex families with familial Mediterranean fever: is a particular genotype necessary for amyloidosis?. Clin Genet 2000; 57: 430–434
   PubMed Web of Science ®Google Scholar
• Amar S, Han X. Regulation of turnour necrosis factor‐α gene expression. Applied Genom Proteom 2002; 1: 31–44
   Google Scholar